Mesothelioma Survival Rates

Mesothelioma Survival Rates








The mesothelioma survival rate is the percentage of people that live for a period of time after diagnosis. The one-year pleural mesothelioma survival rate is about 73%. Unfortunately, less than 12% survive longer than five years. Peritoneal mesothelioma survival rates are much better, with 92% of patients living one year, 52% of patients living five years and about 39% of patients living 10 years or more.

What Are Mesothelioma Survival Rates?

Survival rate typically refers to the percentage of people with cancer who live one and five years after initial diagnosis. These measures are referred to as the one-year and five-year mesothelioma survival rates.
Today deals
Read This Also : How to Make Your First $100 From Google AdSense

When discussing survival rates, you may hear other related terms such as life expectancy, which is the average time a person is expected to live based on birth year, current age, gender and other factors.

Mesothelioma affects life expectancy because the cancer reduces the number of years a patient is expected to live.

Factors Affecting Mesothelioma Survival Rates

There are several things that affect how long a person will live after a mesothelioma diagnosis.

Individual Characteristics and Mesothelioma Survival

  • Tumor Location
  • Stage of disease
  • Mesothelioma cell type
  • Age at diagnosis and overall health
  • Gender
  • Race/Ethnicity

A 2018 analysis of 888 cases in the National Mesothelioma Virtual Bank cohort identified median overall survival of 15 months, on average, for pleural and peritoneal patients combined.

The most important factors associated with better survival were age (less then 45), female gender, epithelioid cell type, stage 1 disease, peritoneal occurrence and treatment combining surgery with chemotherapy.

READ  Sharing The News

Mesothelioma Tumor Location

There are four types of mesothelioma, and the site where the cancer originates affects patient outcomes. Survival is significantly better for peritoneal patients.

An advanced peritoneal mesothelioma therapy called hyperthermic intraperitoneal chemotherapy (HIPEC) has significantly improved survival rates for this cancer.

The procedure combines cytoreductive surgery and heated chemotherapy. Not everyone qualifies for this aggressive procedure, but more than half who do live at least five years.

This compares to a median survival of less than 12 months for patients with pleural tumors. In select studies, heated chemotherapy has boosted peritoneal survival to between 40 and 92 months.

A 2015 meta-study published in Translational Oncology analyzed 20 years of data, collected from 1992 to 2012. The five-year survival rate for peritoneal mesothelioma patients was more than five-times higher than the rate for pleural patients.

 

Author: Anjali Pandey

Hello!Welcome to My Blog Student Rocks